| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |